Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tangent Medical Technologies

Request full access

Intravenous catheters and associated products for the improvement of infusion therapy

Ann Arbor, United StatesFounded 2009Biotechnology

About Tangent Medical Technologies

Tangent Medical Technologies was a development-stage medical device company that operated in the intravenous (IV) therapy market. The firm was established in 2009 as a spin-off from the University of Michigan's Medical Innovation Center. Its conception was based on technology licensed from the university, developed by the company's technical founders: Adrienne Harris, Elyse Kemmerer, Steven White, and Merrell Sami, who were all Fellows at the center. The company focused on creating and commercializing products for IV therapy, targeting a market estimated at $1.3 billion.

The company's flagship product was the NovaCath™ Secure IV Catheter System. This system was designed as a pre-assembled, closed IV catheter that integrated advanced catheter stabilization, passive needle encapsulation, tubing management, and blood control. A key feature was its internal 180-degree fluid path, which eliminated the need for an external J-loop, thereby reducing the risk of snags and dislodgement. The design aimed to improve safety for healthcare workers by minimizing needlestick injuries and blood exposure, while also enhancing patient comfort. The NovaCath system received FDA 510(k) clearance in September 2012, a significant milestone that paved the way for its commercialization.

Following its founding, Tangent Medical Technologies secured initial seed funding from angel investors. In November 2011, it closed a $4.5 million Series A financing round, co-led by Arboretum Ventures and Flagship Ventures. This was followed by another funding round of $8.6 million in late 2012 after receiving FDA approval. The company began accepting commercial orders for the NovaCath system in mid-2013. Ultimately, Tangent Medical Technologies was acquired by ICU Medical, Inc. on April 4, 2016, for $2.6 million.

Source: Dealroom company data

Tangent Medical Technologies in the Ann Arbor ecosystem

Live from Dealroom

The Tangent Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Ann Arbor Spark
  • Osage University Partners

Series A2 investors entered at this stage

Series B and later1 investor entered at this stage

  • GE Capital
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Ann Arbor HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tangent Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tangent Medical Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.